SCHEMBL4598759

SCHEMBL4598759

COc1ccc(C(O[Si](C)(C)C)P(=O)(O)O)cc1C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 7/20 0.38
▸ TAS1R1 Q7RTX1 7/20 0.38
▸ SLC6A2 P23975 2/20 0.38
▸ SLC6A4 P31645 2/20 0.38
▸ SLC6A3 Q01959 2/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ FFAR1 O14842 1/20 0.36
▸ FDPS P14324 2/20 0.35
▸ ACP3 P15309 1/20 0.35
▸ AKR1C3 P42330 1/20 0.34
▸ AKR1C2 P52895 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599288 0.88 CYP1A2 (0.48) CYP1A2CYP2C9CYP2C19KMT2ANPSR1
SCHEMBL4720153 0.74 ACP3 (0.39) KMT2AFDPSACP3
SCHEMBL30536243 0.71 ALDH1A1 (0.39) SLC6A2SLC6A4SLC6A3KMT2AL3MBTL1
SCHEMBL16153835 0.68 SLC6A2 (0.50) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3
SCHEMBL7610341 0.67 AKR1C3 (0.49) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3
SCHEMBL801219 0.67 HDAC4 (0.48) SLC6A2SLC6A4SLC6A3KMT2AAKR1C3
SCHEMBL13304652 0.67 SLC6A2 (0.45) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3
SCHEMBL17224528 0.66 FBP1 (0.44) TAS1R3TAS1R1CYP1A2CYP2C9CYP2C19
SCHEMBL28601945 0.66 TSHR (0.66) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3
SCHEMBL28233452 0.66 TSHR (0.66) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910309-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION Wyeth (US) 2008-04-16 — — EP disclosed
WO-2007016012-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION WYETH (US) 2007-02-08 — — WO disclosed
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation WYETH (US) 2007-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation BACE1, BACE2, APP TAS1R3 4104/4885TAS1R1 4316/4885SLC6A2 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback